U.S. Court of Appeals for the Federal Circuit, 2010

Altana Pharma Ag v. Teva Pharmaceuticals Usa, Inc.

Altana Pharma Ag v. Teva Pharmaceuticals Usa, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided December 8, 2010 · Lourie, Mayer, Dyk
404 F. App'x 477

Altana Pharma Ag v. Teva Pharmaceuticals Usa, Inc.

Opinion

ON MOTION

DYK, Circuit Judge.

ORDER

KUDco Ireland Limited and Schwarz Pharma, Inc. (KUDco) move to stay proceedings in this appeal pending district court action. The court considers whether KUDco’s appeal should be dismissed as premature.

In this consolidated case, Altana Pharma AG and Wyeth sued the defendants for patent infringement. On July 16, 2010 and July 20, 2010, the United States District Court for the District of New Jersey issued an “Order & Final Judgment” against KUDco on its defenses and counterclaims. However, the district court has not entered a final judgment as to all the parties and all the issues, and has not certified the order against KUDco pursuant to Fed. R.Civ.P. 54(b).

Because there are still claims pending before the district court, we deem the better course is to dismiss the appeal as premature. See Nystrom v. TREX Co., 339 F.3d 1347, 1350 (Fed.Cir. 2003). After the district court has adjudicated all the claims of all the parties, or entered a Rule 54(b) judgment, KUDco may file a timely appeal.

Accordingly,

It Is Ordered That:

(1) KUDco’s motion is denied.

(2) The appeal is dismissed.

(3) Each side shall bear its own costs.

(4) All other pending motions are denied as moot.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.